Hydroxy-safflor yellow A inhibits neuroinflammation mediated by Aβ1-42 in BV-2 cells

Neuroscience Letters

Volumn 562, Issue , 2014, Pages 39-44

  Zhang, Zuohui ^a,b   Wu, Zhengzheng ^a   Zhu, Xiaolei ^a   Hui, Xinchen ^a,c   Pan, Jie ^a   Xu, Yun ^a,c,d  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

Beta amyloid; Hydroxy safflor yellow A; Inflammation; Microglia; STAT

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; HYDROXY SAFFLOR YELLOW A; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; JANUS KINASE 2; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NEUROPROTECTIVE AGENT; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CELL; CELL VIABILITY; CYTOTOXICITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MICROGLIA; MTT ASSAY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BETA-AMYLOID; HYDROXY-SAFFLOR YELLOW A; INFLAMMATION; MICROGLIA; STAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL LINE; CHALCONE; HUMANS; INFLAMMATION; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; QUINONES; SIGNAL TRANSDUCTION;

EID: 84893418761     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.005     Document Type: Article

References (22)

1. Benilova I., Karran E., De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 2012, 15:349-357.
2. Bode J.G., Ehlting C., Haussinger D. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal. 2012, 24:1185-1194.
3. Braun D.A., Fribourg M., Sealfon S.C. Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation. J. Biol. Chem. 2013, 288:2986-2993.
4. Chiba T., Yamada M., Sasabe J., Terashita K., Shimoda M., Matsuoka M., Aiso S. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol. Psychiatry 2009, 14:206-222.
5. Cole G.M., Frautschy S.A. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2010, 9:140-148.
6. El Kasmi K.C., Holst J., Coffre M., Mielke L., de Pauw A., Lhocine N., Smith A.M., Rutschman R., Kaushal D., Shen Y., Suda T., Donnelly R.P., Myers M.G., Alexander W., Vignali D.A., Watowich S.S., Ernst M., Hilton D.J., Murray P.J. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 2006, 177:7880-7888.
7. El Kasmi K.C., Smith A.M., Williams L., Neale G., Panopoulos A.D., Watowich S.S., Hacker H., Foxwell B.M., Murray P.J. Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J. Immunol. 2007, 179:7215-7219.
8. Frautschy S.A., Cole G.M. Why pleiotropic interventions are needed for Alzheimer's disease. Mol. Neurobiol. 2010, 41:392-409.
9. He H., Liu Q., Shi M., Zeng X., Yang J., Wu L., Li L. Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats. Phytother. Res. 2008, 22:1107-1114.
10. Heneka M.T., O'Banion M.K., Terwel D., Kummer M.P. Neuroinflammatory processes in Alzheimer's disease. J. Neural Transm. 2010, 117:919-947.
11. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
12. Hutchins A.P., Poulain S., Miranda-Saavedra D. Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. Blood 2012, 119:e110-e119.
13. Kawamata J., Shimohama S. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J. Alzheimers Dis. 2011, 24(Suppl. 2):95-109.
14. Li J., Zhang S., Lu M., Chen Z., Chen C., Han L., Zhang M., Xu Y. Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation. Neurosci. Lett. 2013, 535:51-56.
15. Murray P.J., Smale S.T. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 2012, 13:916-924.
16. O'Shea J.J., Murray P.J. Cytokine signaling modules in inflammatory responses. Immunity 2008, 28:477-487.
17. Rubio-Perez J.M., Morillas-Ruiz J.M. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012, 2012:756357.
18. Sun C.Y., Pei C.Q., Zang B.X., Wang L., Jin M. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice. Phytother. Res. 2010, 24:1788-1795.
19. Takeda K., Akira S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 2000, 11:199-207.
20. Verma S.K., Krishnamurthy P., Barefield D., Singh N., Gupta R., Lambers E., Thal M., Mackie A., Hoxha E., Ramirez V., Qin G., Sadayappan S., Ghosh A.K., Kishore R. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation 2012, 126:418-429.
21. Zhang M.J., Sun J.J., Qian L., Liu Z., Zhang Z., Cao W., Li W., Xu Y. Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice. Brain Res. 2011, 1402:122-131.
22. Zhu X., Chen C., Ye D., Guan D., Ye L., Jin J., Zhao H., Chen Y., Wang Z., Wang X., Xu Y. Diammonium glycyrrhizinate upregulates PGC-1alpha and protects against Abeta1-42-induced neurotoxicity. PLoS ONE 2012, 7:e35823.